A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas

Gene associated with retinoid interferon-induced mortality (GRIM)-19, an inhibitor of transcription factor STAT3, was originally identified as a critical regulatory protein in a genetic screen that was designed to identify the gene products necessary for Interferon (IFN)-β- and retinoic acid-induced cell death. Over expression of GRIM-19 activates cell death. Conversely, inactivation of its expression promotes cell growth. STAT3 is a transcription factor that regulates gene expression in response to multiple extra cellular growth factors. In contrast to its normal feedback inhibition, a constitutive activation of STAT3 has been documented in several tumors. Although many STAT3-inhibitors are described, their relevance to human cancer is unclear. In an attempt to define the molecular alterations associated with human renal cell carcinoma (RCC) using mass spectrometry, we have discovered that expression of GRIM-19 is lost or severely depressed in a number of primary RCC and in some urinogenital tumors. Using an RCC cell line, we show that down regulation of GRIM-19 promotes tumor growth via an augmentation of STAT3-dependent gene expression. These studies for the first time show a tumor-suppressor like activity of GRIM-19.

[1]  A. Kibel,et al.  Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.

[2]  A. Kimchi,et al.  A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. , 1991, Science.

[3]  P. Choyke,et al.  Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. , 1999, The American journal of pathology.

[4]  P. Shapiro,et al.  Identification of GRIM-19, a Novel Cell Death-regulatory Gene Induced by the Interferon-β and Retinoic Acid Combination, Using a Genetic Approach* , 2000, The Journal of Biological Chemistry.

[5]  H. Cai,et al.  Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes , 2002 .

[6]  F. Belardelli,et al.  Endogenous type I interferons as a defense against tumors. , 2002, Cytokine & growth factor reviews.

[7]  Richard J. Simpson,et al.  Proteins and proteomics : a laboratory manual , 2003 .

[8]  L. Baggetto,et al.  Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.

[9]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Q. Zeng,et al.  GRIM-19, a Cell Death Regulatory Protein, Is Essential for Assembly and Function of Mitochondrial Complex I , 2004, Molecular and Cellular Biology.

[11]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[12]  F. McGovern,et al.  Renal-cell carcinoma. , 2005, The New England journal of medicine.

[13]  M. Runswick,et al.  GRIM-19, a Cell Death Regulatory Gene Product, Is a Subunit of Bovine Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I)* , 2001, The Journal of Biological Chemistry.

[14]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[16]  W. Alexander,et al.  The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.

[17]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[18]  J. Choe,et al.  Viral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus Interacts with a Cell Death Regulator, GRIM19, and Inhibits Interferon/Retinoic Acid-Induced Cell Death , 2002, Journal of Virology.

[19]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[20]  Chuan-Yuan Li,et al.  GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth , 2004, Cancer Research.

[21]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[22]  G. Semenza,et al.  Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways , 2005, Oncogene.

[23]  Joe W. Gray,et al.  The Molecular Basis of Cancer , 1985 .

[24]  D. Kalvakolanu The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. , 2004, Cytokine & growth factor reviews.

[25]  J. Barrett,et al.  Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1‐13.2 , 1999, The Prostate.

[26]  Guochang Huang,et al.  GRIM‐19, a death‐regulatory gene product, suppresses Stat3 activity via functional interaction , 2003, The EMBO journal.

[27]  R. Chandraratna,et al.  Therapeutic applications for ligands of retinoid receptors. , 2000, Current pharmaceutical design.

[28]  T. Taniguchi,et al.  Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage , 1996, Nature.

[29]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[30]  T. Kavanagh Gambling, chance and the discourse of power in ancien régime France , 1994 .

[31]  Dillwyn Williams,et al.  Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid , 2005, British Journal of Cancer.

[32]  S. Roy,et al.  The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[34]  D. Kalvakolanu,et al.  Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[35]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[36]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[37]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[38]  H. Moch,et al.  Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma , 2004, Journal of Clinical Pathology.

[39]  P. Houghton,et al.  Potentiation of neuroblastoma metastasis by loss of caspase-8 , 2006, Nature.

[40]  Roland Lang,et al.  SOCS3 regulates the plasticity of gp130 signaling , 2003, Nature Immunology.

[41]  Francesco Pagano,et al.  Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours , 1998, Oncogene.

[42]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[43]  al. et,et al.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.

[44]  Lloyd J. Old,et al.  The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .

[45]  D. Kalvakolanu,et al.  Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo , 2005, Clinical Cancer Research.

[46]  S. Korsmeyer,et al.  Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.

[47]  J. Choe,et al.  Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[48]  Lucia Altucci,et al.  The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.

[49]  I. Tomlinson,et al.  The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase , 2003, Annals of medicine.

[50]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[51]  W. Marston Linehan,et al.  Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.

[52]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[53]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.